AVH News: AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo - 20th Dec 2022, 12:00am

annb0t

Top 20
AVITA Medical

VALENCIA, Calif., and MELBOURNE, Australia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the submission of a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RECELL® System. The application, if approved, will expand the indicati...

>>> Read more: AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
 
Top Bottom